Elucid offers histologically-validated, non-invasive CTA-based software for arterial analysis, enhancing cardiovascular disease diagnosis and treatment with precise, personalized care through its PlaqueIQ technology.
Moximed's MISHA Knee System is an implantable shock absorber designed to relieve pain and improve function in patients with medial knee OA, offering quick recovery and an alternative to knee replacement.
Nuclera's eProtein Discovery system accelerates drug discovery by transforming DNA into active proteins in 48 hours, enabling rapid screening and synthesis of multiple protein constructs and variations.
4basebio specializes in designing and manufacturing custom synthetic DNA and mRNA, offering non-viral vectors for nucleic acid delivery, with advantages over plasmid DNA and non-targeted LNPs.
FIRE1 is a Dublin-based medtech company revolutionizing heart failure care with NORM, a patient-focused platform that empowers millions to regain normal lives through innovative self-management solutions.
